Key result
Ambulatory invasive hemodynamic monitoring shows potential for guiding outpatient levosimendan therapy in advanced HF.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May support guided levosimendan use in advanced HF outpatients; hypothesis-generating and requires larger trials before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Doroteia Silva (2025) studied this question. Ambulatory invasive hemodynamic monitoring is discussed regarding its potential benefit for managing levosimendan therapy in outpatients with advanced heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: